Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with tenofovir/emtricitabine – multicenter comparative trial vs efavirenz in naїve HIV patients

Comparative Trial ◽

Transcriptase Inhibitor ◽

Efficacy And Safety ◽

Hiv Patients ◽

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkq432 ◽

2010 ◽

Vol 66 (2) ◽

pp. 358-362 ◽

Cited By ~ 14

Author(s):

A. Imaz ◽

J. M. Llibre ◽

M. Mora ◽

G. Mateo ◽

A. Camacho ◽

...

Keyword(s):

Reverse Transcriptase ◽

Salvage Therapy ◽

Transcriptase Inhibitor ◽

Multidrug Resistant ◽

Efficacy And Safety ◽

New Class ◽

New Generation ◽

Hiv 1

Efficacy and Safety of Lersivirine Versus Etravirine for the Treatment of HIV-1 Infection in Patients with Prior Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and Evidence of NNRTI Resistance: A Randomized Phase 2B Trial

HIV Clinical Trials ◽

10.1310/hct1505-209 ◽

2014 ◽

Vol 15 (5) ◽

pp. 209-217 ◽

Cited By ~ 1

Author(s):

Edwin DeJesus ◽

Gerd Fätkenheuer ◽

Catherine Orrell ◽

Cunshan Wang ◽

James Jones ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Efficacy And Safety ◽

Nnrti Resistance ◽

Hiv 1

Incidence and risk factors for neuropsychiatric events among Ghanaian HIV patients on long-term non-nucleoside reverse transcriptase inhibitor-based therapy

eNeurologicalSci ◽

10.1016/j.ensci.2015.12.002 ◽

2016 ◽

Vol 3 ◽

pp. 21-25 ◽

Cited By ~ 6

Author(s):

Fred S. Sarfo ◽

Maame A. Sarfo ◽

David Chadwick

Keyword(s):

Risk Factors ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Patients ◽

PIN30 SUBSTITUTION TO LOPINAVIR/RITONAVIR (LPV/R) IS ASSOCIATED WITH IMPROVED PATIENT-REPORTED FATIGUE IN HIV+ PATIENTS EXPERIENCING SIDE EFFECTS RELATED TO THEIR PROTEASE INHIBITOR (PI)/NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)

Value in Health ◽

10.1016/s1098-3015(10)62499-0 ◽

2004 ◽

Vol 7 (3) ◽

pp. 360

Author(s):

MP Luo ◽

Y Shen ◽

R Rode ◽

F McMillan ◽

R Tressler ◽

...

Keyword(s):

Side Effects ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Patients ◽

Patient Reported ◽

Predicted susceptibility of etravirine in HIV patients experiencing virological failure secondary to non-nucleoside reverse transcriptase inhibitor resistance in Argentina

Enfermedades Infecciosas y Microbiología Clínica ◽

10.1016/j.eimc.2011.03.003 ◽

2011 ◽

Vol 29 (6) ◽

pp. 428-431 ◽

Cited By ~ 3

Author(s):

Ezequiel Córdova ◽

Eliana Loiza ◽

Norma Porteiro ◽

Horacio Mingrone

Keyword(s):

Reverse Transcriptase ◽

Virological Failure ◽

Transcriptase Inhibitor ◽

Hiv Patients ◽

Inhibitor Resistance ◽

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkr287 ◽

2011 ◽

Vol 66 (9) ◽

pp. 2194-2194 ◽

Cited By ~ 1

Author(s):

A. Imaz ◽

J. M. Llibre ◽

M. Mora ◽

G. Mateo ◽

A. Camacho ◽

...

Keyword(s):

Reverse Transcriptase ◽

Salvage Therapy ◽

Transcriptase Inhibitor ◽

Multidrug Resistant ◽

Efficacy And Safety ◽

New Class ◽

New Generation ◽

Hiv 1

Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

AIDS ◽

10.1097/qad.0b013e3283584500 ◽

2013 ◽

Vol 27 (1) ◽

pp. 81-85 ◽

Cited By ~ 44

Author(s):

Lourdes Anta ◽

Josep M. Llibre ◽

Eva Poveda ◽

José L. Blanco ◽

Marta Álvarez ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Resistance Mutations ◽

Hiv Patients ◽

Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study

Journal Infectology ◽

10.22625/2072-6732-2018-10-2-76-82 ◽

2018 ◽

Vol 10 (2) ◽

pp. 76-82 ◽

Cited By ~ 2

Author(s):

A. V. Kravchenko ◽

E. A. Orlova-Morozova ◽

T. E. Shimonova ◽

O. A. Kozyrev ◽

F. I. Nagimova ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Treatment ◽

Efficacy And Safety ◽

Reverse Transcriptase Inhibitors ◽

First Line ◽

Faculty Opinions recommendation of Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12019956.13157054 ◽

2011 ◽

Author(s):

Mark Wainberg ◽

Dimitrios Coutsinos

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Subtype C ◽

Low Level ◽

Acute Hiv ◽

Hiv 1

A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma

Current Pharmaceutical Design ◽

10.2174/1381612820666141014125213 ◽

2014 ◽

Vol 21 (7) ◽

pp. 925-935 ◽

Cited By ~ 11

Author(s):

Wen Li ◽

Qian Wang ◽

Yuan Li ◽

Fei Yu ◽

Qi Liu ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Circulation Time ◽

Anti Hiv ◽

Hiv 1